Initial Training Held in Vienna with Leading Spine Surgeons on the
Use of New Technology for Treating the Aging Spine
Products
AGA Medical Receives European CE Mark Approval for AMPLATZER® Cardiac Plug – Device will enable minimally-invasive transcatheter closure of cardiac structures
AGA Medical Corporation announced today that it received European CE Mark approval for its AMPLATZER® Cardiac Plug (ACP). The ACP provides an innovative, minimally invasive solution for closing cardiac structures not involving the septal wall.
St. Jude Medical Celebrates the 50th Anniversary of the World’s First Implantable Pacemaker
St. Jude Medical, Inc. (NYSE: STJ ) celebrates the 50th anniversary of the world’s first implantable pacemaker.
Eden Spine Receives CE Mark for its Nonfusion Wellex™ Interspinous Process Medical Device
“Wellex device fills the gap between conservative care and fusion surgery in early-stage degenerative disc disease.”
Guillaume Viallaneix, CEO, Eden Spine
Covidien Introduces the SprayShield™ Adhesion Barrier System to the European Marketplace
Sprayable hydrogel technology in treatment of post-surgical adhesions
Better Insights Needed Into Failure Mechanisms Of Hip Replacements
Why do hip replacements fail?
CAMBfix – Funding For Device Which Improves Fracture Care
CAMBfix announced that it has received funding to develop CAMBfix technology which allows for the treatment of broken bones without the need for an open operation.
Anika signs distribution agreement with DePuy Mitek
Anika Therapeutics has signed an exclusive agreement with DePuy Mitek, to distribute and market Orthovisc and Orthovisc mini throughout Latin America
Duke Study: Knee Replacement Improves Mobility at Any Age
For patients who suffer from osteoarthritis of the knee, total knee replacement is a cost-effective
procedure that leads to greater mobility and independent living — even for
those in their 80s or 90s.
Once-Yearly Aclasta® Approved In EU To Treat Male Osteoporosis And To Reduce Risk Of New Fractures Following Hip Fracture In Both Sexes
The European Commission has approved once-yearly Aclasta®* (zoledronic acid 5 mg) for the treatment of osteoporosis in men who are at increased risk of fractures.
NOVA™ Now Available in Europe
NOVA™, the most advanced technology to quantitatively and non-invasively measure blood flow using magnetic resonance imaging, will now be available to vascular patients in Europe
Boston Scientific Announces Court Decision
Boston Scientific Corporation has announced a decision by the United States District Court in Delaware regarding a patent owned by Johnson & Johnson and Boston Scientific’s NIR® stent product
PlasmaJet® Named ‘Innovation of the Year’ by the Society of Laparoendoscopic Surgeons
Plasma Surgical Ltd.has announced that its flagship product, PlasmaJet®, has been named an “Innovation of the Year” by the Society of Laparoendoscopic Surgeons
Live Total Knee Replacement Webcast
Live Total Knee Replacement Webcast Eases Patient Concerns
Cardiac Dimensions®, Inc. Announces Key Personnel Changes
Two important additions to Cardiac Dimension®’s senior management team. Mr. Paul Cornelison recently joined the company as Vice President of Regulatory Affairs and Quality Assurance. In addition, Mr. Nawzer Mehta, Ph.D., has joined the company as Vice President of Clinical Affairs.
Boston Scientific to Participate in UBS Global Life Sciences Conference
Boston Scientific Corporation is scheduled to participate in the UBS Global Life Sciences Conference, which is being held September 22 … continue reading “Boston Scientific to Participate in UBS Global Life Sciences Conference”